Cardiovascular precision medicine: Bad news from the front?

[1]  Martin Hofmann-Apitius,et al.  Towards a 21st-century roadmap for biomedical research and drug discovery: consensus report and recommendations. , 2017, Drug discovery today.

[2]  J. Beckmann,et al.  Reconciling evidence-based medicine and precision medicine in the era of big data: challenges and opportunities , 2016, Genome Medicine.

[3]  J. Rumsfeld,et al.  Can Big Data Fulfill Its Promise? , 2016, Circulation. Cardiovascular quality and outcomes.

[4]  Jie Zheng,et al.  Knowledge-guided fuzzy logic modeling to infer cellular signaling networks from proteomic data , 2016, Scientific Reports.

[5]  J. Rumsfeld,et al.  Big data analytics to improve cardiovascular care: promise and challenges , 2016, Nature Reviews Cardiology.

[6]  M. Joyner.  Precision Medicine, Cardiovascular Disease and Hunting Elephants. , 2016, Progress in cardiovascular diseases.

[7]  T. Helms,et al.  Challenges in personalised management of chronic diseases—heart failure as prominent example to advance the care process , 2015, EPMA Journal.

[8]  Zhibin Wang,et al.  Elusive inheritance: Transgenerational effects and epigenetic inheritance in human environmental disease. , 2015, Progress in biophysics and molecular biology.

[9]  D. Longo,et al.  Precision medicine--personalized, problematic, and promising. , 2015, The New England journal of medicine.

[10]  F. Collins,et al.  A new initiative on precision medicine. , 2015, The New England journal of medicine.

[11]  A. Bottle,et al.  Can valid and practical risk-prediction or casemix adjustment models, including adjustment for comorbidity, be generated from English hospital administrative data (Hospital Episode Statistics)? A national observational study , 2014 .

[12]  Michael J Joyner,et al.  Chasing Mendel: five questions for personalized medicine , 2014, The Journal of physiology.

[13]  Erika Check Hayden,et al.  Technology: The $1,000 genome , 2014, Nature.

[14]  R. Vasan,et al.  Genetics of Coronary Artery Disease , 2013, Circulation.

[15]  D. Jordan,et al.  Large Numbers of Genetic Variants Considered to be Pathogenic are Common in Asymptomatic Individuals , 2013, Human mutation.

[16]  D. Noble.  Physiology is rocking the foundations of evolutionary biology , 2013, Experimental physiology.

[17]  M. Caulfield,et al.  Genes for blood pressure: an opportunity to understand hypertension. , 2013, European heart journal.

[18]  Samuli Ripatti,et al.  From genetic discovery to future personalized health research , 2013, New biotechnology.

[19]  Bernadette A. Thomas,et al.  Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010 , 2012, The Lancet.

[20]  I. Buchan,et al.  Contributions of treatment and lifestyle to declining CVD mortality: why have CVD mortality rates declined so much since the 1960s? , 2012, Heart.

[21]  Hugo Y. K. Lam,et al.  Personal Omics Profiling Reveals Dynamic Molecular and Medical Phenotypes , 2012, Cell.

[22]  Dimitrios H Roukos,et al.  Networks medicine: from reductionism to evidence of complex dynamic biomolecular interactions. , 2011, Pharmacogenomics.

[23]  Denis Noble,et al.  Neo‐Darwinism, the Modern Synthesis and selfish genes: are they of use in physiology? , 2011, The Journal of physiology.

[24]  Nancy R Cook,et al.  Association between a literature-based genetic risk score and cardiovascular events in women. , 2010, JAMA.

[25]  S. Humphries,et al.  Utility of genetic and non-genetic risk factors in prediction of type 2 diabetes: Whitehall II prospective cohort study , 2010, BMJ : British Medical Journal.

[26]  J. Shapiro.  Revisiting the Central Dogma in the 21st Century , 2009, Annals of the New York Academy of Sciences.

[27]  Cornelia M van Duijn,et al.  Genome-based prediction of common diseases: advances and prospects. , 2008, Human molecular genetics.

[28]  Peter M Visscher,et al.  Prediction of individual genetic risk of complex disease. , 2008, Current opinion in genetics & development.

[29]  Masahiro Fukuoka,et al.  Predict, prevent and personalize: Genomic and proteomic approaches to cardiovascular medicine. , 2007, The Canadian journal of cardiology.

[30]  M. Pembrey,et al.  Sex-specific, male-line transgenerational responses in humans , 2006, European Journal of Human Genetics.

[31]  Wei Hu,et al.  Cytoplasmic Impact on Cross-Genus Cloned Fish Derived from Transgenic Common Carp (Cyprinus carpio) Nuclei and Goldfish (Carassius auratus) Enucleated Eggs1 , 2005, Biology of reproduction.

[32]  F. Collins,et al.  A vision for the future of genomics research , 2003, Nature.

[33]  V. Rakyan,et al.  Transgenerational inheritance of epigenetic states at the murine AxinFu allele occurs after maternal and paternal transmission , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[34]  F. Collins,et al.  Contemplating the end of the beginning. , 2001, Genome research.

[35]  J. Cutler,et al.  Trends and disparities in coronary heart disease, stroke, and other cardiovascular diseases in the United States: findings of the national conference on cardiovascular disease prevention. , 2000, Circulation.

[36]  E. Lander.  The New Genomics: Global Views of Biology , 1996, Science.

[37]  B. Mcclintock,et al.  The significance of responses of the genome to challenge. , 1984, Science.

[38]  Atrial fibrillation: the role of common and rare genetic variants , 2022 .